EA therapy for CCH with hypertension may be mediated via downregulation of the hippocampal ACE/Ang II/AT1R axis and upregulation of the hippocampal ACE2/Ang-(1-7)/MasR axis. Here, MAS1L is linked to hypertensive disorder.